MAPK-RAP1A Signaling Enriched in Hepatocellular Carcinoma Is Associated With Favorable Tumor-Infiltrating Immune Cells and Clinical Prognosis

BACKGROUND: MAPK-RAP1A signaling, which is involved in cancer progression, remains to be defined. Upregulation of MAPK-RAP1A signaling accounts for most cancers that harbor high incident rate, such as non-small cell lung cancer (NSCLC) and pancreatic cancer, especially in hepatocellular carcinoma (H...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hailin, Han, Guangyu, Li, Xing, Li, Bowen, Wu, Bo, Jin, Hongyuan, Wu, Lingli, Wang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222816/
https://www.ncbi.nlm.nih.gov/pubmed/34178637
http://dx.doi.org/10.3389/fonc.2021.649980

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222816/
https://www.ncbi.nlm.nih.gov/pubmed/34178637
http://dx.doi.org/10.3389/fonc.2021.649980

Ejemplares similares